Drugmakers Face Tough Free Speech Fight on List Prices in TV Ads

June 21, 2019, 9:45 AM

Free speech protections will be at the center of a legal fight early next month as pharmaceutical companies challenge a new federal rule requiring them to disclose drug list prices in television ads.

Merck & Co., Eli Lilly and Co., Amgen Inc., and an advertising trade association filed a lawsuit June 14 in federal court, claiming the Centers for Medicare & Medicaid Services lacks the statutory authority to impose such a requirement.

The final rule came out May 8 and takes effect July 9, giving drug companies little time to challenge it. The parties are scheduled to be in the ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.